Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation’s approach to vaccinating people against COVID-19.
Hours after the Food and Drug Administration authorized booster doses of COVID-19 vaccine for all adults 18 years and older, a panel of experts endorsed their use with a few caveats.
A third of people under 35 said cost led them to put off some form of health care, compared with only 8 percent of people 65 and older, a poll by NPR and IBM Watson Health found.
While a majority of Americans know about naloxone, there is confusion about the fact that in most places a prescription isn’t required to obtain the emergency overdose treatment.
A surgeon at Brigham and Women’s Hospital in Boston, Gawande is probably best known for his work writing about how to improve quality and lower costs in health care.